Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors
Conditions
Interventions
SGN-ALPV
Locations
13
United States
Women's Cancer Care
Fresno, California, United States
Yale Cancer Center
New Haven, Connecticut, United States
Florida Cancer Specialists - Lake Nona
Wellington, Florida, United States
START Midwest
Grand Rapids, Michigan, United States
Oklahoma University at Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
START Mountain Region
West Valley City, Utah, United States
Start Date
April 21, 2022
Primary Completion Date
December 13, 2023
Completion Date
December 13, 2023
Last Updated
February 10, 2025
NCT06855771
NCT06120140
NCT04895709
NCT07213804
NCT04165798
NCT06667908
Lead Sponsor
Seagen Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions